Zhenyang Cai, CTO

Zhenyang Cai

FreedomAI CTO

Multimodal medical model R&D

  • PhD candidate, The Chinese University of Hong Kong, Shenzhen
  • Contributor to HuatuoGPT-o1, DentalGPT and other models
  • First-author papers at NeurIPS and ACL
1,168Google Scholar citations (Nov 2026)
9h-index
NeurIPS · ACLfirst-author (incl. co-first) papers

Biography

Zhenyang Cai is the CTO of FreedomAI, leading multimodal medical model R&D while pursuing a PhD at The Chinese University of Hong Kong, Shenzhen.

He contributed to medical large models including HuatuoGPT-Vision and HuatuoGPT-o1 (second author), and is first or co-first author of the dental multimodal large model DentalGPT (Findings of ACL 2026), the multinational dental benchmark GlobalDentBench, a study of compositional generalization in medical imaging (ACL 2025), native alignment in Arabic LLM pre-training (NeurIPS 2024) and the traditional Chinese medicine multimodal model ShizhenGPT (Findings of EMNLP 2026).

In 2026, the HuatuoGPT-Vision-2 paper he contributed to was selected as a NeurIPS 2026 Oral, and the pathology foundation model CMD and the microscopic-world benchmark MicroVerse were published at NeurIPS 2026 and ICLR 2026. As of November 2026, his papers have 1,168 citations on Google Scholar, with an h-index of 9.

Selected publications 21

Selected publications; see Google Scholar for the full list.

2026

2025

2024

Related News

Other members

← Back to Core Team